Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M207Revenue $M96.0Net Margin (%)-10.4Z-Score-0.3
Enterprise Value $M194EPS $-0.2Operating Margin %-10.6F-Score6
P/E(ttm))0Cash Flow Per Share $-0.3Pre-tax Margin (%)-10.3Higher ROA y-yY
Price/Book5.610-y EBITDA Growth Rate %-4.7Quick Ratio1.3Cash flow > EarningsY
Price/Sales2.15-y EBITDA Growth Rate %-18.8Current Ratio1.6Lower Leverage y-yY
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)-16.6Higher Current Ratio y-yY
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)-28.6Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M44.5ROI % (ttm)-75.6Gross Margin Increase y-yY

Gurus Latest Trades with ENZ

Number of guru portfolios checked: 84. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
ENZDodge & Cox 2014-09-30 Buy $4.55 - $6.08
($5.34)
$ 4.64-13%New holding, 15570 sh.15,570
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

ENZ is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
ENZ Dodge & Cox 2014-09-3015,5700.030New Buy
Premium Most recent portfolio changes are included for Premium Members only!


ENZ: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
KASTEN BERNARD LDirector 2014-10-24Sell15,900$4.93-7.51view
RABBANI ELAZARCEO and Secretary 2011-11-16Buy20,000$2.2999.13view
WEINER BARRY WPres, CFO, Princ AO and Treasr 2011-11-16Buy20,000$2.2999.13view
BALEZENTIS CARL WPres., Enzo Life Sciences 2010-12-15Sell12,724$5.12-10.94view
Kent Stephen B HDirector 2010-10-22Sell8,000$4.36.05view
Kent Stephen B HDirector 2010-08-05Sell2,500$4.472.01view
Kent Stephen B HDirector 2010-06-11Sell5,000$4.296.29view
Kent Stephen B HDirector 2010-03-15Sell5,000$6.15-25.85view
KRENITSKY KEVINPresident, Enzo Clinical Labs 2009-10-15Buy6,600$7.7-40.78view
BALEZENTIS CARL WPresident, Enzo Life Sciences 2008-10-30Sell580$5.35-14.77view

Press Releases about ENZ :

    Quarterly/Annual Reports about ENZ:

    News about ENZ:

    Articles On GuruFocus.com
    Weekly CFO Buys Highlight: BWEN, DDMG, ZHNE, ENZ, SIRO Nov 28 2011 
    Weekly CFO Buys Highlight: BWEN, ENZ, PIP, HAFC, AACC Nov 21 2011 
    Enzo Biochem Inc. Reports Operating Results (10-Q) Mar 14 2011 
    Enzo Biochem Inc. Reports Operating Results (10-Q) Dec 10 2010 
    Enzo Biochem Inc. Reports Operating Results (10-Q) Jun 09 2010 
    Enzo Biochem Inc. Reports Operating Results (10-Q) Dec 10 2009 
    Weekly Top Insider Buys: Bank of America Corp., Safeway Inc., Umpqua Holdings Corp., National Penn B Oct 24 2009 
    Weekly Top Insider Buys: KB Home, National Penn Bancshares Inc., Moduslink Global Solutions Inc., En Oct 20 2009 
    Enzo Biochem Inc. Reports Operating Results (10-Q) Sep 04 2009 
    Enzo Biochem Inc. (ENZ) Files Quarterly Report for the Period Ended on 2008-10-31 Dec 15 2008 


    More From Other Websites
    Enzo Biochem (ENZ) in Focus: Stock Moves 6.9% Higher Nov 24 2014
    What Falling Estimates & Price Mean for Enzo Biochem (ENZ) Oct 17 2014
    ENZO BIOCHEM INC Financials Oct 16 2014
    Enzo Biochem Inc Earnings Call scheduled for 8:30 am ET today Oct 10 2014
    ENZO BIOCHEM INC Files SEC form 8-K, Results of Operations and Financial Condition, Regulation FD... Oct 09 2014
    Enzo Biochem Reports Strong Fiscal Fourth Quarter Results Oct 09 2014
    Q4 2014 Enzo Biochem Inc Earnings Release - After Market Close Oct 09 2014
    Enzo Biochem Awarded Patent for Novel Vectors Involving Gene Therapy Treatments for Cancer, Virus... Oct 07 2014
    Enzo Biochem Schedules Teleconference to Discuss Fourth Quarter Results Friday, October 10, 2014 at... Oct 06 2014
    Cambrex Corporation (CBM) in Focus: Stock Up 7.3% Aug 04 2014
    Thomas C Wright, MD, World Recognized Women’s Health Sciences Authority, Joins Enzo Biochem’s... Jul 31 2014
    Strength Seen in Aegerion Pharmaceuticals, Inc. (AEGR): Stock Shoots up 16.4% Jul 31 2014
    Enzo Biochem Announces August 18, 2014 as Date of Markman Hearing in Patent Infringement Lawsuit... Jul 29 2014
    Enzo Biochem Added to Russell 2000 and Russell 3000 Indexes Jun 30 2014
    ENZO BIOCHEM INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial... Jun 23 2014
    Earnings Estimates Moving Higher for Enzo Biochem (ENZ): Time to Buy? Jun 17 2014
    ENZO BIOCHEM INC Files SEC form 8-K, Results of Operations and Financial Condition, Regulation FD... Jun 09 2014
    Enzo Biochem Reports Strong Third Fiscal Quarter Results Jun 09 2014
    Enzo Biochem Awarded U.S. Patent on More Efficient Vector for Use in Gene Therapy Jun 06 2014
    Enzo Biochem Schedules Teleconference to Discuss Third Quarter Results Tuesday, June 10, 2014 at... Jun 03 2014

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK